Rankings
Pricing
Log In
Free Trial
US-listed companies
Vor Biopharma Inc.
Vor Biopharma Inc.
VOR
Market cap
$45.52M
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2021
Dec 31,
2022
Research and development
48
65
General and administrative
21
29
Total operating expenses
69
93
Loss from operations
-69
-93
Interest income
0
1
Total other income
0
1
Net loss
-69
-92
Cumulative dividends on redeemable convertible preferred stock
1
-
Net loss attributable to common stockholders
-70
-92
Earnings Per Share, Basic
-
-2.33
Earnings Per Share, Diluted
-
-2.33
Unrealized gain (loss) on available for sale investments
-
-1
Total other comprehensive loss
-
-1
Comprehensive loss attributable to common stockholders
-
-93